Oculeve was a start-up consumer/med. tech. company with a first-in-class connected neuromodulation technology to address an unmet clinical need in ophthalmology. Early investors included KPCB, NEA, and Versant. In August 2015, Oculeve was acquired by Allergan Plc.
Company’s Keywords:
biotechnology, life sciences
<2
<6000000
<2011